# Neither uni- nor multi-modal exercise interventions improved single- and dual-task gait performance in physically active healthy elderly – a pilot study

**Authors:** Constantin W. Freitag, Martin Behrens, Robert Bielitzki, Tom Behrendt, Khaldoon O. Al-Nosairy, Francie H. Stolle, Gokulraj T. Prabhakaran, Rosalie Beyer, Cynthia Moffack Djuloun, Hagen Thieme, Michael B. Hoffmann, Lutz Schega

PMC · DOI: 10.1186/s12877-025-06537-w · BMC Geriatrics · 2025-11-04

## TL;DR

A 12-week study found that neither combined nor single resistance training improved walking or cognitive performance in active older adults, despite increased strength.

## Contribution

This pilot study compares multimodal and unimodal exercise interventions on gait and cognitive performance in elderly individuals.

## Key findings

- Neither multimodal nor unimodal interventions improved gait parameters in elderly participants.
- Cognitive performance did not improve after either type of intervention.
- Resistance training increased external load, suggesting neuromuscular adaptations, but no functional gains in gait or cognition.

## Abstract

Aging is an inevitable process leading, inter alia, to the loss of muscle mass as well as the decrease in physical and cognitive function. These age-related impairments translate into a reduced gait performance and an increased risk of falls, which can be tackled with resistance training, Unimodal intervention (UMI). However, Multimodal intervention (MMI), i.e. combined motor-cognitive and resistance training, might be a more promising approach to increase physical and cognitive function in old adults. Therefore, this pilot study aimed to investigate the effects of MMI, compared to UMI, on gait and cognitive performance in elderly participants. We hypothesized that MMI will increase gait and cognitive performance to a larger extent than UMI.

In this two-arm randomized controlled pilot study, 24 healthy active elderly participants completed the MMI (12 participants, 72.6 ± 5.4 years) and the UMI (12 participants, 70.4 ± 5.3 years). Both groups trained for 12 weeks, two times a week for 60 min, respectively. MMI consisted of motor-cognitive training directly followed by resistance training, while UMI consisted of a stand-alone resistance training. Three weeks before and after the interventions, gait performance (e.g., stride length, velocity, minimum toe clearance) was assessed during single- and dual-task walking trials using inertial measurement units. During dual-task walking, participants walked and concurrently performed different cognitive tasks in a random order: (i) reaction time task, (ii) N-back-task, and (iii) letter fluency task with two difficulty levels, respectively. Data were analyzed with repeated measures analyses of covariance (Time×Intervention×Condition).

Although the analyses of the progression of the external load used during resistance training showed a significant increase over the training period (e.g. leg press p < 0.001,\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:{{\upeta\:}}_{\text{p}}^{2}$$\end{document}=0.678), there was no improvement of gait or cognitive performance in active old adults after neither MMI nor UMI.

Against our hypothesis, the present pilot study indicated that neither a 12-week MMI nor UMI seems to have a sizable impact on gait parameters and cognitive performance in physically active healthy adults. Still, a significant increase in the external load used during resistance training was observed, implying neuromuscular adaptations, which, however, did not translate into a higher gait and/or cognitive performance.

German Clinical Trial Register ID: DRKS00022519/05.08.2020

The online version contains supplementary material available at 10.1186/s12877-025-06537-w.

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}
- **Diseases:** loss of muscle mass (MESH:C536030), MTC (MESH:D000070592), arthrosis (MESH:D010003), neurological disorders (MESH:D009461), open angle glaucoma (MESH:D005902), myositis (MESH:D009220), stroke (MESH:D020521), white matter lesion (MESH:D056784), falling (MESH:C537863), Curl (MESH:D004381), white matter atrophy (MESH:D000090122), Lever leg extension (MESH:D000079822), skeletal muscle atrophy (MESH:D009133), sarcopenia (MESH:D055948), injuries (MESH:D014947), cognitive dysfunction (MESH:D003072), eye diseases (MESH:D005128), tenosynovitis (MESH:D013717), glaucoma (MESH:D005901), musculoskeletal impairment (MESH:D009140), gait impairments (MESH:D020234), age (MESH:D019588), rheumatism (MESH:D012216), cardiovascular disorders (MESH:D002318), COVID-19 (MESH:D000086382), tendinitis (MESH:D052256), Seated (MESH:C569516), DTC (MESH:D009105)
- **Species:** Gammacoronavirus (genus) [taxon 694013], Drosophila melanogaster (fruit fly, species) [taxon 7227], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** RPE — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12584342/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12584342/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12584342/full.md

---
Source: https://tomesphere.com/paper/PMC12584342